SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 104.93 |
| Enterprise Value ($M) | 296.19 |
| Book Value ($M) | -159.65 |
| Book Value / Share | -1.27 |
| Price / Book | -0.66 |
| NCAV ($M) | -164.37 |
| NCAV / Share | -1.31 |
| Price / NCAV | -0.64 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.80 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.93 |
| Current Ratio | 3.00 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 184.75 |
| Assets | 189.48 |
| Liabilities | 349.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avidity Partners Management LP | 3.70 | -57.63 | |
| 13G/A | Vanguard Group Inc | 6.13 | 0.00 | |
| 13G | Highbridge Capital Management Llc | 7.20 | ||
| 13G/A | BlackRock, Inc. | 3.50 | -58.60 | |
| 13G | J. Wood Capital Advisors Llc | 5.50 | ||
| 13G/A | Palo Alto Investors LP | 4.45 | -9.79 | |
| 13G/A | Rubric Capital Management LP | 0.00 | -100.00 | |
| 13G/A | State Street Corp | 1.79 | -7.17 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 206,243 | 834,559 | 24.71 | |
| 97,723 | 388,569 | 25.15 | |
| 159,339 | 501,870 | 31.75 | |
| 139,569 | 534,758 | 26.10 | |
| 308,413 | 911,629 | 33.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JAZZ – Jazz Pharmaceuticals plc | KMDA – Kamada Ltd. |
| KNSA – Kiniksa Pharmaceuticals, Ltd. | KRON – Kronos Bio, Inc. |
| KRYS – Krystal Biotech, Inc. |
Financial data and stock pages provided by
Fintel.io